Related Experiment Video
Updated: Jun 28, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Cardamom consumption may improve cardiovascular metabolic biomarkers in adults: A systematic review and meta-analysis
Xiaofeng Zhang1, Caixia Wang1, Ruixue Min1
1Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Zhengzhou 450001, Henan, China.
Cardamom consumption may improve cardiovascular health by lowering total cholesterol and triglycerides, and reducing inflammation markers like C-reactive protein. Further research is needed to confirm these benefits for heart health.
Area of Science:
- Nutritional Science
- Cardiovascular Health
- Metabolic Biomarkers
Background:
- Cardamom's bioactive compounds are linked to improved cardiovascular health.
- Existing research on cardamom's impact on cardiac metabolism shows debate.
- Cardiovascular diseases remain a leading global health concern.
Purpose of the Study:
- To investigate the effects of cardamom consumption on lipid profiles.
- To assess cardamom's impact on inflammatory markers and oxidative stress.
- To determine cardamom's potential role in ameliorating cardiovascular metabolic biomarkers.
Main Methods:
- A systematic review and meta-analysis of randomized controlled trials.
- Searched major databases including PubMed, Scopus, Embase, Web of Science, and Cochrane Library.
- Included 12 trials with 989 participants, using a random-effects model.
Main Results:
- Cardamom significantly reduced total cholesterol and triglycerides.
- It also decreased high-sensitivity C-reactive protein and interleukin-6 levels.
- No significant effects were observed on HDL cholesterol, LDL cholesterol, or oxidative stress indicators.
Conclusions:
- Cardamom consumption demonstrates potential benefits for cardiovascular health by improving key metabolic biomarkers.
- The findings suggest cardamom may offer protective effects against cardiovascular diseases.
- Larger, well-designed clinical trials are recommended to validate these results.
More Related Videos
13:09Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet
Published on: July 31, 2021
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Pathophysiology of Cardiac Performance
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Adrenergic Antagonists: ɑ and β-Receptor Blockers